logo
#

Latest news with #priceTarget

Krystal Biotech price target lowered to $182 from $192 at BofA
Krystal Biotech price target lowered to $182 from $192 at BofA

Yahoo

time6 days ago

  • Business
  • Yahoo

Krystal Biotech price target lowered to $182 from $192 at BofA

BofA analyst Alec Stranahan lowered the firm's price target on Krystal Biotech (KRYS) to $182 from $192 and keeps a Buy rating on the shares. While there were some positives from the Q2 report, the firm expects investors will be concerned about the near-term growth trajectory given management expects Q3 revenue to be below Q2 based on patient pausing trends. Following the quarterly report, the firm updated its model to reflect decreased near-term Vyjuvek revenues and pushed back launches for KB407 and KB408. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on KRYS: Disclaimer & DisclosureReport an Issue Krystal Biotech: Strong Financial Performance and Strategic Global Expansion Justify Buy Rating Video: Why These Stocks Are Moving Today Krystal Biotech reports Q2 EPS $1.29, consensus $1.44 Is KRYS a Buy, Before Earnings? Positive Phase 1 Trial Results for KB304 Bolster Buy Rating for Krystal Biotech Amidst Promising Market Potential Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

MasTec price target raised to $213 from $193 at Jefferies
MasTec price target raised to $213 from $193 at Jefferies

Yahoo

time28-06-2025

  • Business
  • Yahoo

MasTec price target raised to $213 from $193 at Jefferies

Jefferies raised the firm's price target on MasTec (MTZ) to $213 from $193 and keeps a Buy rating on the shares. MasTec had 'solid' momentum in Q2, with a focus on end-market strength, backlog, and margins, the analyst tells investors in a research note. Jefferies views shares as among most compelling across its coverage. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on MTZ: Disclaimer & DisclosureReport an Issue MasTec upgraded to Buy from Neutral at Goldman Sachs MasTec price target raised to $181 from $171 at Stifel MasTec Confirms Directors and Approves Key Proposals Charter upgraded, Cisco downgraded: Wall Street's top analyst calls MasTec initiated with a Buy at Jefferies 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤

Planet Labs price target raised to $8 from $7 at Northland
Planet Labs price target raised to $8 from $7 at Northland

Yahoo

time28-06-2025

  • Business
  • Yahoo

Planet Labs price target raised to $8 from $7 at Northland

Northland raised the firm's price target on Planet Labs (PL) to $8 from $7 and keeps an Outperform rating on the shares after the company participated in the firm's Capital Growth conference this week. The CEO said international demand 'is the likes of which he has never seen before,' adding that opportunities outweigh risk in U.S., the firm tells investors. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on PL: Disclaimer & DisclosureReport an Issue Largest borrow rate increases among liquid names Planet Labs PBC call volume above normal and directionally bullish Planet Labs price target raised to $8.50 from $6.30 at Cantor Fitzgerald Planet Labs rises 13.5% Unusually active option classes on open June 12th

Nike price target raised to $85 from $73 at Truist
Nike price target raised to $85 from $73 at Truist

Yahoo

time28-06-2025

  • Business
  • Yahoo

Nike price target raised to $85 from $73 at Truist

Truist raised the firm's price target on Nike (NKE) to $85 from $73 and keeps a Buy rating on the shares after its Q4 results. The company's turnaround efforts are yielding more rapid improvements than investors were anticipating as channel inventories are getting cleaned up and with holiday orderbooks rising y/y, the analyst tells investors in a research note. While visibility into a return to sales growth and margin recovery appears meaningfully stronger, the stock is still down 15% from where it traded prior to the initial announcement that Elliott Hill was taking over as CEO in September, but with the worst of fundamental pressures appearing to be in the rear-view, there is plenty of room to run, the firm added. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on NKE: Disclaimer & DisclosureReport an Issue Nike's Strategic Positioning and Growth Potential Earns Buy Rating Despite Revenue Decline Nike price target raised to $88 from $80 at Baird Nike price target raised to $80 from $70 at Piper Sandler Options Volatility and Implied Earnings Moves Today, June 27, 2025 Nike price target raised to $64 from $56 at JPMorgan Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Mettler-Toledo price target raised to $1,260 from $1,200 at BofA
Mettler-Toledo price target raised to $1,260 from $1,200 at BofA

Yahoo

time27-06-2025

  • Business
  • Yahoo

Mettler-Toledo price target raised to $1,260 from $1,200 at BofA

BofA raised the firm's price target on Mettler-Toledo (MTD) to $1,260 from $1,200 and keeps a Neutral rating on the shares. The firm is updating its price targets for stocks under its coverage in the Life Sciences & Diagnostic Tools, LSTs, sector, the analyst tells investors. The firm notes LSTs remain under pressure as uncertainty persists with the macro environment and U.S. government policies. Recent weeks, however, have seen some signs of improvement as tariff concerns have cools slightly, the firm adds. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on MTD: Disclaimer & DisclosureReport an Issue Mettler-Toledo initiated with an Overweight at Barclays Citi adds 'upside 90-day short-term view' on Mettler-Toledo MongoDB and Asana downgraded: Wall Street's top analyst calls UBS upgrades Mettler-Toledo to Buy into growth reacceleration UBS upgrades Mettler-Toledo to Buy ahead of growth reacceleration Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store